Business Wire India

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD

Brand Post · Jun 4, 2025

Ant International Pushes AI Strategy with AI Platform for Fintechs

Brand Post · Jun 4, 2025

OpenGMSL™ Association Announces Formation to Revolutionize the Future of In-Vehicle Connectivity

Brand Post · Jun 4, 2025

LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams

Brand Post · Jun 4, 2025

Automotive Industry Shifts Gears As Talent and Technology Take Center Stage

Brand Post · Jun 4, 2025

H Company Launches Next-Generation Autonomous AI Agents for Enterprise and Consumer Markets

Brand Post · Jun 4, 2025

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

Brand Post · Jun 4, 2025

dataplor Raises $20.5M Series B to Scale Global Location Intelligence and Accelerate Product Growth

Brand Post · Jun 4, 2025

The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit

Brand Post · Jun 4, 2025

LTTS and Tennant Company Sign Strategic Agreement to Advance Sustainable New Product Development

Brand Post · Jun 4, 2025

Greek-Indian “Eutopia” Marks a New Chapter in Greek-Indian Manpower Mobility

Brand Post · Jun 3, 2025

Venture Global Launches Site Work at CP2 LNG Following Federal Approval

Brand Post · Jun 3, 2025

Deel Surpasses $1 Billion Run Rate, Signaling a New Era in Global HR

Brand Post · Jun 3, 2025

BELFOR Highlights Digital Transformation in Damage Assessment at Asia Claims Convention 2025 in Osaka

Brand Post · Jun 3, 2025

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

Brand Post · Jun 3, 2025

Business

Stock Market

Finance

Tech

Sports

Entertainment

Sectors

Lifestyle

More

Latest Articles by Business Wire India

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD

Ant International Pushes AI Strategy with AI Platform for Fintechs

OpenGMSL™ Association Announces Formation to Revolutionize the Future of In-Vehicle Connectivity

LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams

Automotive Industry Shifts Gears As Talent and Technology Take Center Stage

H Company Launches Next-Generation Autonomous AI Agents for Enterprise and Consumer Markets

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

dataplor Raises $20.5M Series B to Scale Global Location Intelligence and Accelerate Product Growth

The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit

LTTS and Tennant Company Sign Strategic Agreement to Advance Sustainable New Product Development

Greek-Indian “Eutopia” Marks a New Chapter in Greek-Indian Manpower Mobility

Venture Global Launches Site Work at CP2 LNG Following Federal Approval

Deel Surpasses $1 Billion Run Rate, Signaling a New Era in Global HR

BELFOR Highlights Digital Transformation in Damage Assessment at Asia Claims Convention 2025 in Osaka

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US